EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitNetzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes

Suryono Suryono iD, Muhammad Farhan Hibatulloh iD, Alfiyah Ramadhani iD, Candra Agung Wibisana iD, Muhammad Naufal Hibatullah iD, Achmad Ilham Tohari iD, Muhammad Rijal Fahrudin Hidayat iD, Muhammad Irsyad Amien iD, Hazbina Fauqi Ramadhan iD

European Cardiology Review · 30.10.2026

DOI: 10.15420/ecr.2026.29 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 30.10.2026. Verfasst von Suryono Suryono und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Jember - Dr Soebandi General Hospital Jember, Indonesia. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal antiplatelet therapy after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) requires balancing thrombotic protection and bleeding risk, but the comparative effectiveness of current strategies remains uncertain.

Aims

To evaluate the risk–benefit profile of oral antiplatelet strategies after PCI with DES, focusing on major bleeding and stent thrombosis.

Methods

A network meta-analysis of randomised and observational studies was conducted. Strategies included standard or extended dual antiplatelet therapy (DAPT), shortened DAPT followed by monotherapy and P2Y12 inhibitor-based monotherapy. Outcomes were analysed using a random-effects model and ranked with p-scores. Evidence certainty was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE).

Results

Thirty studies involving 110,035 patients were included. Ticagrelor monotherapy ranked highest for reducing major bleeding, whereas extended DAPT provided the greatest protection against stent thrombosis, with clopidogrel-based therapy beyond 12 months ranking highest (RR 0.08; 95% CI [0.01–0.52]; p-score=0.94). Notably, clopidogrel monotherapy after prolonged DAPT demonstrated a relatively balanced profile across both outcomes. However, no strategy was consistently optimal and most estimates showed wide CIs.

Conclusion

Antiplatelet strategies after PCI with DES involve a clear trade-off between bleeding and thrombotic risk. Clopidogrel monotherapy after prolonged DAPT may offer a balanced approach, although findings should be interpreted cautiously due to limited precision and consistency.

Schlagwörter

Stichwörter der Autor:innen

Antiplatelet therapydrug-eluting stentstrade-off

Autor:innen und Institutionen

  • Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Jember - Dr Soebandi General Hospital Jember, Indonesia.
  • Faculty of Medicine, Universitas Jember Jember, Indonesia.
  • Department of Epidemiology and Preventive Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University Kagoshima, Japan.
  • Kalisat General Hospital Jember, Indonesia.

ORCID-Profile: Suryono Suryono, Muhammad Farhan Hibatulloh, Alfiyah Ramadhani, Candra Agung Wibisana, Muhammad Naufal Hibatullah, Achmad Ilham Tohari, Muhammad Rijal Fahrudin Hidayat, Muhammad Irsyad Amien, Hazbina Fauqi Ramadhan

Zitieren

APA

Suryono, S., Hibatulloh, M. F., Ramadhani, A., Wibisana, C. A., Hibatullah, M. N., Tohari, A. I., Hidayat, M. R. F., Amien, M. I., & Ramadhan, H. F. (2026). Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes. European Cardiology Review. https://doi.org/10.15420/ecr.2026.29

Vancouver

Suryono S, Hibatulloh MF, Ramadhani A, Wibisana CA, Hibatullah MN, Tohari AI, et al. Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes. European Cardiology Review. 2026. doi:10.15420/ecr.2026.29

BibTeX
@article{Suryono2026,
  author = {Suryono, Suryono and Hibatulloh, Muhammad Farhan and Ramadhani, Alfiyah and Wibisana, Candra Agung and Hibatullah, Muhammad Naufal and Tohari, Achmad Ilham and Hidayat, Muhammad Rijal Fahrudin and Amien, Muhammad Irsyad and Ramadhan, Hazbina Fauqi},
  title = {Risk–Benefit Profile of Oral Antiplatelet Strategies After Percutaneous Coronary Intervention with a Drug-eluting Stent: A Contemporary Network Meta-analysis of Major Bleeding and Stent Thrombosis Outcomes},
  journal = {European Cardiology Review},
  year = {2026},
  doi = {10.15420/ecr.2026.29}
}
Kostenlos starten →